These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6135036)

  • 21. Head case.
    Park A
    Time; 2013 Jun; 181(21):16. PubMed ID: 24044241
    [No Abstract]   [Full Text] [Related]  

  • 22. Biologic tests in psychiatry.
    Sternberg DE
    Psychiatr Clin North Am; 1984 Sep; 7(3):639-50. PubMed ID: 6435102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet MAO-B, personality, and psychopathology.
    Ruchkin VV; Koposov RA; af Klinteberg B; Oreland L; Grigorenko EL
    J Abnorm Psychol; 2005 Aug; 114(3):477-82. PubMed ID: 16117585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical profile of depressed adolescents.
    Khan AU
    J Am Acad Child Adolesc Psychiatry; 1987 Nov; 26(6):873-8. PubMed ID: 3123454
    [No Abstract]   [Full Text] [Related]  

  • 25. Serotonin transporter, tryptophan hydroxylase, and monoamine oxidase A gene polymorphisms in premenstrual dysphoric disorder.
    Magnay JL; Ismail KM; Chapman G; Cioni L; Jones PW; O'Brien S
    Am J Obstet Gynecol; 2006 Nov; 195(5):1254-9. PubMed ID: 17026953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment.
    Brown WA; Johnston R; Mayfield D
    Am J Psychiatry; 1979 Apr; 136(4B):543-7. PubMed ID: 426140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degeneration of dopaminergic neurons induced by thrombin injection in the substantia nigra of the rat is enhanced by dexamethasone: role of monoamine oxidase enzyme.
    Argüelles S; Herrera AJ; Carreño-Müller E; de Pablos RM; Villarán RF; Espinosa-Oliva AM; Machado A; Cano J
    Neurotoxicology; 2010 Jan; 31(1):55-66. PubMed ID: 19969022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoamine oxidase, tobacco smoking, and psychiatric disorders.
    Domino EF
    Biol Psychiatry; 1996 Sep; 40(5):433-4. PubMed ID: 8874851
    [No Abstract]   [Full Text] [Related]  

  • 29. Current research on biological markers.
    Kasper S
    World J Biol Psychiatry; 2014 Jan; 15(1):1. PubMed ID: 24410178
    [No Abstract]   [Full Text] [Related]  

  • 30. Proteomic biomarkers for psychiatric disorders: a progress update.
    Martins-de-Souza D; Turck CW
    Biomark Med; 2012 Apr; 6(2):189-92. PubMed ID: 22448792
    [No Abstract]   [Full Text] [Related]  

  • 31. [Monoamine oxidase and its inhibitors. Physiological, physiopathological and pharmacotherapeutic considerations].
    Constantinescu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1978; 23(4):303-12. PubMed ID: 370952
    [No Abstract]   [Full Text] [Related]  

  • 32. Monoamine oxidase, monoamine oxidase inhibitors, and panic disorder.
    Norman TR; Burrows GD
    J Neural Transm Suppl; 1989; 28():53-63. PubMed ID: 2677243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixture distributions in psychiatric research.
    Gibbons RD; Dorus E; Ostrow DG; Pandey GN; Davis JM; Levy DL
    Biol Psychiatry; 1984 Jul; 19(7):935-61. PubMed ID: 6477998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone suppression test: a review of contemporary confusion.
    Carroll BJ
    J Clin Psychiatry; 1985 Feb; 46(2 Pt 2):13-24. PubMed ID: 3881417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoamines (4): monoamine oxidase activity in psychiatric diseases].
    Oreland L
    Lakartidningen; 1978 Feb; 75(8):665-7. PubMed ID: 634001
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biologic markers and prediction of response to treatment in depression].
    Uytdenhoef P; Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):229-42. PubMed ID: 6187184
    [No Abstract]   [Full Text] [Related]  

  • 37. Informed use of the dexamethasone suppression test.
    Carroll BJ
    J Clin Psychiatry; 1986 Jan; 47(1 Suppl):10-2. PubMed ID: 3941065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
    Baker GB; Sowa B; Todd KG
    J Psychiatry Neurosci; 2007 Sep; 32(5):313-5. PubMed ID: 17823646
    [No Abstract]   [Full Text] [Related]  

  • 39. Methylene blue: a reliable and practical marker for validating compliance on the DST.
    Kraus RP; Grof P; Arana GW; Workman RJ; Harvey KJ; Hux M
    J Clin Psychiatry; 1987 Jun; 48(6):224-9. PubMed ID: 3294814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic formulation.
    Rusk TN
    Am J Psychiatry; 1969 Oct; 126(4):578-9. PubMed ID: 5806806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.